PLCG2 mutation
|
Follicular Lymphoma
|
PLCG2 mutation
|
Follicular Lymphoma
|
R-CHOP Resistant: C3 – Early Trials
|
R-CHOP Resistant: C3 – Early Trials
|
PLCG2 mutation
|
MDS
|
PLCG2 mutation
|
MDS
|
lenalidomide Resistant: C3 – Early Trials
|
lenalidomide Resistant: C3 – Early Trials
|
PLCG2 mutation
|
CLL
|
PLCG2 mutation
|
CLL
|
venetoclax Sensitive: C3 – Early Trials
|
venetoclax Sensitive: C3 – Early Trials
|
PLCG2 mutation
|
CLL
|
PLCG2 mutation
|
CLL
|
ibrutinib Resistant: C3 – Early Trials
|
ibrutinib Resistant: C3 – Early Trials
|